Supradiaphragmatic Liver Confirmed by a Hepatocyte-specific Contrast Agent (Gd-EOB-DTPA): A Case Report.
10.13104/imri.2015.19.1.52
- Author:
Young Jong CHO
1
;
Hyuk Jung KIM
;
Young A BAE
;
Suk Ki JANG
;
Jae Woo YEON
Author Information
1. Department of Radiology, Daejin Medical Center Bundang Jesaeng General Hospital, Seongnam-si, Gyeonggi-do, Korea. hyukjungk@naver.com
- Publication Type:Case Report
- Keywords:
Supradiaphragmatic liver;
MRI;
Hepatocyte-specific contrast agent;
Gadoxetic acid (Gd-EOB-DTPA, Primovist);
Intrathoracic mass
- MeSH:
Diagnosis;
Hepatocytes;
Liver*;
Lung;
Magnetic Resonance Imaging
- From:Investigative Magnetic Resonance Imaging
2015;19(1):52-55
- CountryRepublic of Korea
- Language:English
-
Abstract:
Supradiaphragmatic liver is a rare condition. Establishing an accurate preoperative diagnosis is difficult. Operative exploration is necessary to differentiate this lesion from intrathoracic masses, such as a pleural based tumor, diaphragmatic tumor and peripheral lung tumor. However, with the aid of the hepatocyte-specific magnetic resonance imaging contrast agent, gadoxetic acid (Gd-EOB-DTPA), functional hepatocytes in the lesion can be identified in the hepatobiliary phase, potentially allowing an accurate and non-invasive diagnosis. We report a case of supradiaphragmatic liver diagnosed by Gd-EOB-DTPA-enhanced magnetic resonance imaging.
